Role of microbiology laboratory in diagnosis of sars cov-2 (Covid-19)

Role of microbiology laboratory in diagnosis of sars cov-2 (Covid-19)

Saved in:

Bibliographic Details
Main Author:	Madhulika Mistry
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2021-01-01
Series:	NMO Journal
Online Access:	https://journals.lww.com/10.53772/NMO.2021.15105
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Restraining SARS-CoV-2 in histopathology laboratory amid COVID-19 pandemic
by: Efosa Bolaji Odigie, et al.
Published: (2022-01-01)

Factors associated with SARS-CoV-2 RNAemia development at COVID-19 diagnosis
by: Javier Martín-Escolano, et al.
Published: (2025-01-01)

Laboratory diagnosis of emerging human infections by SARS-COVID-19: Prevalence and challenges
by: Soumya Nigam, et al.
Published: (2022-06-01)

An overview of SARS-COV-2 (COVID-19) disease pandemic
by: Sagorika Rai, et al.
Published: (2020-08-01)

Research progress of SARS-CoV-2 and COVID-19
by: Nan CHEN, et al.
Published: (2021-06-01)

New Coronavirus COVID-19 (SARS-CoV-2)
by: O. V. Shamsheva
Published: (2020-03-01)

Fat embolism and COVID-19 infection: autopsy and post-mortem laboratory findings in SARS-CoV-2 positive patients
by: Adriana Gavronova, et al.
Published: (2025-06-01)

Unraveling Dysgeusia in SARS-CoV-2 Infection: Clinical and Laboratory Insights from Hospitalized COVID-19 Patients in Romania
by: Elena Camelia Kouris, et al.
Published: (2025-03-01)

Post Covid Fungal Infection
by: Dr Mistry Madhulika
Published: (2022-01-01)

Exploring the long-term seroprevalence of SARS-CoV-2 antibodies in infants born to women with clinical or laboratory-confirmed COVID-19
by: Uswa Jiwani, et al.
Published: (2024-05-01)

Host-dependent editing of SARS-CoV-2 in COVID-19 patients
by: Josep Gregori, et al.
Published: (2021-01-01)

Proposed therapies and vaccine developing for COVID-19 (SARS CoV-2)
by: Gamal, Abdelaziz, et al.
Published: (2020-06-01)

Spatiotemporal prevalence of COVID-19 and SARS-CoV-2 variants in Africa
by: Li-Ping Gao, et al.
Published: (2025-02-01)

Highly Prevalent SARS-CoV-2 Antigenemia in COVID-19 Patients
by: Wenyan Zhang, et al.
Published: (2022-07-01)

No credible evidence supporting claims of the laboratory engineering of SARS-CoV-2
by: Shan-Lu Liu, et al.
Published: (2020-01-01)

Characteristics of SARS-CoV-2 testing for rapid diagnosis of COVID-19 during the initial stages of a global pandemic.
by: Jennifer L Guthrie, et al.
Published: (2021-01-01)

Seroprevalence of anti-SARS-CoV-2 antibodies in Japanese COVID-19 patients.
by: Makoto Hiki, et al.
Published: (2021-01-01)

Coinfection with SARS-CoV-2 and Cytomegalovirus in a Patient with Mild COVID-19
by: Kazuya Ura, et al.
Published: (2023-01-01)

COVID-19 patient variables associated with the detection of airborne SARS-CoV-2
by: Joan Truyols-Vives, et al.
Published: (2025-08-01)

Return to training after coronavirus (SARS-CoV-2/COVID-19) infection
by: I. E Zelenkova, et al.
Published: (2020-12-01)

nSARS-CoV-2 and COVID-19 Pandemic: From Emergence to Vaccination
by: Imran Shahid
Published: (2022-01-01)

COVID-19 Symptomatic Newborns with Possible Postpartum Transmission of SARS-CoV-2
by: Mohammad Hosein Ataee Nakhaei, et al.
Published: (2022-01-01)

The biology of SARS-CoV-2 and epidemiological analysis of COVID-19 pandemic in Nigeria
by: Kingsley Andrew Egbe, et al.
Published: (2022-02-01)

SARS-CoV2 neuroinvasive potential in respiratory failure in COVID-19 patients
by: Hamidreza Hassanzadeh Khanmiri, et al.
Published: (2023-04-01)

Emerging SARS-CoV-2 Variants in Uganda in the Era of COVID-19 Vaccination
by: Nicholas Bbosa, et al.
Published: (2024-11-01)

Insights into SARS-CoV-2: Small-Molecule Hybrids for COVID-19 Treatment
by: Maria Luisa Navacchia, et al.
Published: (2024-11-01)

MECHANISM OF SARS-COV-2 INVASION INTO THE LIVER AND HEPATIC INJURY IN PATIENTS WITH COVID-19
by: XiaoTian Zhang, et al.
Published: (2022-01-01)

SARS-CoV-2 Transmission From People Without COVID-19 Symptoms
by: article editotial
Published: (2021-03-01)

The potential role of the combined PARP-1 and VEGF inhibition in severe SARS-CoV-2 (COVID-19) infection
by: Dimitra Ioanna Lampropoulou, et al.
Published: (2022-01-01)

The Changing Culture of the Microbiology Laboratory
by: Kevin B Laupland, et al.
Published: (2013-01-01)

Retrospective Analysis of the Impact of SARS-CoV-2 (COVID-19) on Pregnancy and Neonatal Outcomes
by: Leyla Sero, et al.
Published: (2024-01-01)

Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient
by: Jing Sun, et al.
Published: (2020-01-01)

Dynamic surveillance of SARS-CoV-2 shedding and neutralizing antibody in children with COVID-19
by: Pengcheng Liu, et al.
Published: (2020-01-01)

Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China
by: Rossella Porcheddu, et al.
Published: (2020-02-01)

Fractional Optimal Control Model of SARS-CoV-2 (COVID-19) Disease in Ghana
by: Samuel Okyere, et al.
Published: (2023-01-01)

The evolving picture of SARS-CoV-2 and COVID-19 in children: critical knowledge gaps
by: Priscilla Idele, et al.
Published: (2020-09-01)

Tracking the progress of inequalities in SARS-CoV-2 infections into the third covid-19 wave
by: Charles Agyemang, et al.
Published: (2023-10-01)

Severe COVID-19 and inactivated vaccine in diabetic patients with SARS-CoV-2 infection
by: Yaling Yang, et al.
Published: (2025-05-01)

Correction: Comparing methods to classify admitted patients with SARS-CoV-2 as admitted for COVID-19 versus with incidental SARS-CoV-2: A cohort study.
by: PLOS One Staff
Published: (2025-01-01)

Role of Oral Microbiome in the SARS-COV-2 Pandemic
by: Deepa Jatti Patil
Published: (2021-01-01)